Construction completion of the Cancer Institute's shelled space on floors 9 and 1

描述（由申请人提供）：阿肯色州大学医学科学温斯洛普P.洛克菲勒癌症研究所是一家新兴的癌症中心，其专业领域包括：基于基因表达谱的多发性骨髓瘤个性化治疗;药物基因组学和分子流行病学;以及循环肿瘤细胞的激光检测。癌症研究所的两个主要塔楼将门诊临床护理和研究楼层与实验室研究楼层混合在一起。随着扩建塔的完工和一位新的具有白血病转化研究专业知识的医生兼科学家主任的招聘，癌症研究所处于独特的地位，可以为阿肯色州及其他地区的公民推动研究驱动的癌症治疗。本申请的目的是请求资金支持在癌症研究所扩建大楼的第9层和第11层研究实验室楼层建造33，660净平方英尺的带壳空间。这些楼层将与新完成的平移输液楼层以及专门用于研究药物的新药房相互作用。该项目是通过设计开发（DD）进行的，具有创新，协作和环保的实验室空间设计，但缺乏进一步发展的资金。因此，该项目可以真正被视为“准备就绪”，并将立即创造约125个建筑和建筑工作岗位。更重要的是，它将使癌症研究所能够招募近12名新的翻译研究人员，加上博士后研究员，技术人员和其他支持人员，这将加快基于机制的分子靶向新型癌症疗法的翻译。

DESCRIPTION (provided by applicant): The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences is an emerging cancer center with areas of expertise in, amongst others: personalized medicine for multiple myeloma based on gene expression profiling; pharmacogenomics and molecular epidemiology; and laser detection of circulating tumor cells. Both of the Cancer Institute's two main towers inter-mingle outpatient clinical care and research floors with floors devoted to laboratory research. With the completion of the expansion tower and the recruitment of a new physician-scientist director with expertise in leukemia translational research, the Cancer Institute is uniquely positioned to propel research-driven cancer treatment for the citizens of Arkansas and beyond. The purpose of this application is to request funds to support the build out of 33,660 net square feet of shelled space on the 9th and 11th research laboratory floors of the Cancer Institute's expansion tower. These floors will interact with newly completed translational infusion floors, and a new pharmacy devoted to investigational agents. This project was through Design Development (DD) with an innovative, collaborative, and environmentally-friendly lab space design, but lacked funding to take it further. Thus, this project can truly be regarded as "shovel-ready," and will immediately create ~125 construction and architectural jobs. Even more importantly, downstream it will enable the Cancer Institute to recruit nearly a dozen new translational research faculty, plus post-doctoral fellows, technicians, and other support staff which will speed the translation of mechanism-based, molecularly-targeted novel cancer therapeutics to the clinic.